The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126938841 12693884 1 I 201608 20160822 20160829 20160829 PER US-PFIZER INC-2016397975 PFIZER 57.00 YR F Y 80.29000 KG 20160829 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126938841 12693884 1 PS VENLAFAXINE HCL VENLAFAXINE HYDROCHLORIDE 1 Oral 225MG IN THE MORNING AND 75MG AT NIGHT, 2X/DAY 20699 PROLONGED-RELEASE CAPSULE BID
126938841 12693884 2 SS VENLAFAXINE HCL VENLAFAXINE HYDROCHLORIDE 1 Oral 300 MG, DAILY 20699 300 MG PROLONGED-RELEASE CAPSULE
126938841 12693884 3 SS VENLAFAXINE HCL VENLAFAXINE HYDROCHLORIDE 1 Oral 150MG PLUS 75MG IN THE MORNING AND 75MG AT NIGHT, 2X/DAY 20699 PROLONGED-RELEASE TABLET BID
126938841 12693884 4 SS VENLAFAXINE HCL VENLAFAXINE HYDROCHLORIDE 1 Oral 300 MG, DAILY 20699 300 MG PROLONGED-RELEASE TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126938841 12693884 1 Sleep disorder
126938841 12693884 3 Sleep disorder

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126938841 12693884 Agitation
126938841 12693884 Anxiety
126938841 12693884 Asthenia
126938841 12693884 Crying
126938841 12693884 Depression
126938841 12693884 Disease recurrence
126938841 12693884 Feeling abnormal
126938841 12693884 Intentional product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found